Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Communications
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. nature communications
  3. articles
  4. article
An engineered viral RNA degrader on mitochondrial surface that mitigates RNA virus infection
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 19 May 2026

An engineered viral RNA degrader on mitochondrial surface that mitigates RNA virus infection

  • Chih-Wei Chen  ORCID: orcid.org/0000-0002-1401-48201,2 na1,
  • Wei-Ting Liao1 na1,
  • Tung Chao  ORCID: orcid.org/0000-0003-3641-49961,2,
  • Yi-Han Chen1,
  • Shih-Che Weng  ORCID: orcid.org/0000-0003-3315-91253,
  • Shin-Hong Shiao3,
  • Ching-Yang Kao4,
  • Yun-Jung Li  ORCID: orcid.org/0009-0005-9965-80334,
  • Kai-An Cheng  ORCID: orcid.org/0009-0001-7989-14964 &
  • …
  • Zee-Fen Chang  ORCID: orcid.org/0000-0003-3011-284X1,2 

Nature Communications (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Mechanisms of disease
  • Nucleic-acid therapeutics
  • Viral infection

Abstract

Infections by RNA viruses cause diseases. Host factor(s) that restrain viral propagation offer new anti-virus strategies. We use vesicular stomatitis virus (VSV) as a model and observe the synthesis of VSV RNAs at mitochondria/endoplasmic reticulum (Mito/ER) spheres, accompanied by the leakage of endonuclease G (ENDOG), a mitochondrial nuclease, to the cytosol. We provide evidence that ENDOG released from mitochondria is a host anti-viral factor by eliminating viral RNAs for replication. However, ENDOG outside mitochondria can translocate to nuclei and cause nuclear DNA damages. We engineer an ENDOG expressed on mitochondrial outer membrane (MOM), namely MOM-ENDOG, to increase the accessibility to viral RNA transcripts synthesized at mitochondrial sites without damaging nuclear DNA (nDNA). Delivery of modified mRNA of wild-type but not catalytic-dead MOM-ENDOG markedly suppresses not only the propagation of VSV, but also Dengue and Zika virus. Thus, this organelle-specific viral RNA degrader may be developed as a broad-spectrum anti-viral agent.

Acknowledgements

We thank the National RNAi Core Facility, Academia Sinica for ENDOG and LacZ shRNA plasmids. We thank the image core, the Biomedical Resource Core at the First Core Labs at College of Medicine National Taiwan University for the technical assistance. We thank Professor Chien-Kuo Lee and Li-Chung Hsu (National Taiwan University, Taiwan) for providing VSV and HIN1 virus.

Funding

C.-W.C. was supported by a grant from National Science and Technology Council, Taiwan (NSTC114-2811-B-002-107). W.-T.L. was supported by a grant from National Science and Technology Council, Taiwan (NSTC114-2811-B-002-090). T.C. was supported by a grant from Ministry of Education Higher Education SPROUT Project, Taiwan (113L4000-2).

Author information

Author notes
  1. These authors contributed equally: Chih-Wei Chen, Wei-Ting Liao.

Authors and Affiliations

  1. Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

    Chih-Wei Chen, Wei-Ting Liao, Tung Chao, Yi-Han Chen & Zee-Fen Chang

  2. Center of Nucleic Acid Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

    Chih-Wei Chen, Tung Chao & Zee-Fen Chang

  3. Department of Tropical Medicine and Parasitology, College of Medicine, National Taiwan University, Taipei, Taiwan

    Shih-Che Weng & Shin-Hong Shiao

  4. Center for Frontier Medicine, National Taiwan University Hospital, Taipei, Taiwan

    Ching-Yang Kao, Yun-Jung Li & Kai-An Cheng

Authors
  1. Chih-Wei Chen
    View author publications

    Search author on:PubMed Google Scholar

  2. Wei-Ting Liao
    View author publications

    Search author on:PubMed Google Scholar

  3. Tung Chao
    View author publications

    Search author on:PubMed Google Scholar

  4. Yi-Han Chen
    View author publications

    Search author on:PubMed Google Scholar

  5. Shih-Che Weng
    View author publications

    Search author on:PubMed Google Scholar

  6. Shin-Hong Shiao
    View author publications

    Search author on:PubMed Google Scholar

  7. Ching-Yang Kao
    View author publications

    Search author on:PubMed Google Scholar

  8. Yun-Jung Li
    View author publications

    Search author on:PubMed Google Scholar

  9. Kai-An Cheng
    View author publications

    Search author on:PubMed Google Scholar

  10. Zee-Fen Chang
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Zee-Fen Chang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information (download PDF )

Reporting Summary (download PDF )

Transparent Peer Review file (download PDF )

Source data

Source Data (download ZIP )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, CW., Liao, WT., Chao, T. et al. An engineered viral RNA degrader on mitochondrial surface that mitigates RNA virus infection. Nat Commun (2026). https://doi.org/10.1038/s41467-026-73487-1

Download citation

  • Received: 03 June 2025

  • Accepted: 13 May 2026

  • Published: 19 May 2026

  • DOI: https://doi.org/10.1038/s41467-026-73487-1

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Videos
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Aims & Scope
  • Editors
  • Journal Information
  • Open Access Fees and Funding
  • Calls for Papers
  • Editorial Values Statement
  • Journal Metrics
  • Editors' Highlights
  • Contact
  • Editorial policies
  • Top Articles

Publish with us

  • For authors
  • For Reviewers
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature Communications (Nat Commun)

ISSN 2041-1723 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research